An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma
Abstract Background While some lung adenocarcinoma (LUAD) patients benefit long-term from treatment with immune checkpoint inhibitors, the sad reality is that a considerable proportion of patients do not. The classification of the LUAD tumor microenvironment (TME) can be used to conceptually compreh...
Main Authors: | Yuxin Wu, Kexin Li, Shuang Liang, Xiaoying Lou, Yiling Li, Danfei Xu, Yue Wu, Yuan Wang, Wei Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02443-0 |
Similar Items
-
Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
by: Yingshu Cui, et al.
Published: (2023-08-01) -
Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma
by: Dongxiao Ding, et al.
Published: (2023-12-01) -
Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
by: Xiaotian He, et al.
Published: (2023-06-01) -
A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
by: Kaibin Zhu, et al.
Published: (2022-06-01) -
Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma’s Prognosis and Immune Landscape
by: Xinyue Liu, et al.
Published: (2024-01-01)